Literature DB >> 7691388

Plasma extravasation induced by neurokinins in conscious rats: receptor characterization with agonists and antagonists.

M Nicolau1, M G Sirois, M Bui, G E Plante, P Sirois, D Regoli.   

Abstract

The purpose of the present experiments was to study the effects of various neurokinin related peptides, such as substance P, [beta Ala8]NKA(4-10), and [MePhe7]NKB, which are selective for NK-1, NK-2, and NK-3 functional sites, respectively, to induce plasma extravasation in rats and the effectiveness of RP 67580 and CP-96,345 (two nonpeptide NK-1 receptor selective antagonists) and SR 48968 (a nonpeptide NK-2 receptor selective antagonist) to prevent such an effect. Bolus intravenous injection of substance P (1.0 nmol/kg) into conscious rats induced extravasation of Evans blue dye (EB), a selective marker of albumin vascular permeability, in the duodenum, the stomach, the pancreas, and the urinary bladder by 50, 40, 58, and 312%, respectively; a slight increment occurred also in the ileum and the kidney but was not significant. [beta Ala8]NKA(4-10) (1.0 nmol/kg) increased EB extravasation in the stomach and the urinary bladder by 52 and 99%, respectively, while [MePhe7]NKB (1.0 nmol/kg) did the same in the stomach, the ileum, and the urinary bladder by 58, 50, and 79%. Pretreatment with RP 67580 (250 nmol/kg) blocked the albumin extravasation mediated by substance P in the duodenum, the pancreas, and the urinary bladder by 100, 100, and 78%, respectively. CP-96,345 (250 nmol/kg) also inhibited EB extravasation mediated by substance P in the duodenum and the pancreas by 100 and 100%, respectively, but was ineffective in the urinary bladder. Neither RP 67580 nor CP-96,345 prevented the substance P mediated extravasation in the stomach. RP 67580 and CP-96,345 did not antagonize the effects of NK-2 and NK-3 selective agonists.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691388     DOI: 10.1139/y93-034

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  5 in total

1.  Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice.

Authors:  E F Grady; S K Yoshimi; J Maa; D Valeroso; R K Vartanian; S Rahim; E H Kim; C Gerard; N Gerard; N W Bunnett; K S Kirkwood
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

2.  Vascular endothelial growth factor increases permeability of the blood-tumor barrier via caveolae-mediated transcellular pathway.

Authors:  Li-ni Zhao; Zhi-hang Yang; Yun-hui Liu; Hao-qiang Ying; Hua Zhang; Yi-xue Xue
Journal:  J Mol Neurosci       Date:  2010-12-31       Impact factor: 3.444

3.  TRPV1 activation results in disruption of the blood-brain barrier in the rat.

Authors:  De-En Hu; Alexander S Easton; Paul A Fraser
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

4.  Plasma extravasation mediated by lipopolysaccharide-induction of kinin B1 receptors in rat tissues.

Authors:  P R Wille; R Vitor; N H Gabilan; M Nicolau
Journal:  Mediators Inflamm       Date:  2001-06       Impact factor: 4.711

5.  Enhancement of blood-tumor barrier permeability by Sar-[D-Phe8]des-Arg9BK, a metabolically resistant bradykinin B1 agonist, in a rat C6 glioma model.

Authors:  Ronie Cleverson Cardoso; Bruno Lobão-Soares; Marino Muxfeldt Bianchin; Carlos Gilberto Carlotti; Roger Walz; Márcio Alvarez-Silva; Andréa Gonçalves Trentin; Mauro Nicolau
Journal:  BMC Neurosci       Date:  2004-09-30       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.